Darman Ara Company
Darman Ara Company is a private Tehran-based pharmaceutical importer and distributor founded in 2000 and operating within Darman Ara Holding. It registers, markets and supplies pharmaceutical products, plasma-derived medicines, medical devices, nutritional supplements and medical nutrition in Iran. The company is a relevant route-to-market partner for specialty healthcare suppliers and an indicator of Iran’s regulated therapeutic-import supply chain.
Operations & footprint
Products and services
Darman Ara Company imports, registers, markets, and distributes pharmaceutical products, plasma-derived products, medical devices, hospital products, nutritional supplements, clinical nutrition products, specialty medicines, and related healthcare goods. Its activity is linked to foreign principal relationships, product registration, import logistics, medical-device supply, plasma collection and plasma-product access, hospital channels, and regulated healthcare distribution.
Operations and assets
The wider group includes two active plasmapheresis centres operated by Daya Arian Darou and a plasma refinery built by Plasma Darman Pharmed for albumin and immunoglobulin production.
Geographic footprint
Tehran-based operations serving the Iranian healthcare market.
Ownership & group structure
Ownership
Private company within Darman Ara Holding.
Parent company
Darman Ara Holding (درمان آرا هلدینگ).
Subsidiaries and group companies
Related group entities include Daya Arian Darou Company, which operates two active plasmapheresis centres, and Plasma Darman Pharmed, which has built a plasma refinery for albumin and immunoglobulin production.
Commercial and investment relevance
Darman Ara is relevant for investors assessing Iran's pharmaceutical import dependence, specialty-drug access, plasma-derived product supply, medical-device distribution, clinical nutrition, hospital procurement, and compliance-sensitive healthcare channels. It can support analysis of how foreign principals, product registrations, currency access, sanctions, banking limits, and regulated distribution affect availability of higher-value healthcare products. Due diligence should verify current supplier agreements, product registrations, ownership, import licenses, payment routes, plasma-center relationships, distribution partners, cold-chain controls, medical-device approvals, receivables, and any sanctions or counterparty-screening exposure. Darman Ara connects overseas healthcare-product principals with Iranian registration, import and distribution channels. It is particularly relevant to suppliers of plasma-derived therapies, medical nutrition, specialty medicines and medical devices seeking an Iranian market route.
Constraints, risk & compliance
Key risks and constraints
The business depends on regulated product registration and import execution for specialised healthcare goods. Continuity in plasma-derived product supply also depends on the operating status and capacity of the group’s plasma-collection and fractionation assets.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Darman Ara Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Darman Ara Company do?
Darman Ara imports, registers, markets and distributes pharmaceutical products, plasma-derived medicines, medical devices, nutritional supplements and medical-nutrition products in Iran.
Where is Darman Ara Company based?
Darman Ara is headquartered in Saadat Abad, Tehran, Iran.
Is Darman Ara involved in plasma-derived medicines?
Yes. Its portfolio includes coagulation factors, intravenous immunoglobulin, albumin and other plasma-derived therapies. Its wider group also includes plasma-collection and plasma-fractionation activities.
Who owns Darman Ara Company?
Darman Ara is a private company within Darman Ara Holding.